BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33356838)

  • 1. Tissue specific diversification, virulence and immune response to
    Korol CB; Shallom SJ; Arora K; Boshoff HI; Freeman AF; King A; Agrawal S; Daugherty SC; Jancel T; Kabat J; Ganesan S; Torrero MN; Sampaio EP; Barry C; Holland SM; Tettelin H; Rosenzweig SD; Zelazny AM
    Virulence; 2020 Dec; 11(1):1656-1673. PubMed ID: 33356838
    [No Abstract]   [Full Text] [Related]  

  • 2. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.
    Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH
    mBio; 2016 May; 7(3):. PubMed ID: 27222470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice.
    Aldwell FE; Tucker IG; de Lisle GW; Buddle BM
    Infect Immun; 2003 Jan; 71(1):101-8. PubMed ID: 12496154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis.
    Jouanguy E; Lamhamedi-Cherradi S; Altare F; Fondanèche MC; Tuerlinckx D; Blanche S; Emile JF; Gaillard JL; Schreiber R; Levin M; Fischer A; Hivroz C; Casanova JL
    J Clin Invest; 1997 Dec; 100(11):2658-64. PubMed ID: 9389728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Idiopathic disseminated infection by BCG or atypical mycobacteria].
    Casanova JL
    Arch Pediatr; 1997 Sep; 4(9):883-5. PubMed ID: 9345572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phylogenomic and epidemiological insights into two clinical Mycobacterium bovis BCG strains circulating in South Africa.
    Modipane L; Reva O; Magazi BT; Antiabong JF; Osei Sekyere J; Mbelle NM
    Int J Infect Dis; 2019 Oct; 87():32-38. PubMed ID: 31442625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rifampicin-resistant Mycobacterium bovis BCG strain isolated from an infant with NEMO mutation].
    Çavuşoğlu C; Edeer Karaca N; Azarsız E; Ulusoy E; Kütükçüler N
    Mikrobiyol Bul; 2015 Apr; 49(2):272-7. PubMed ID: 26167828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of cattle with a high dose of BCG vaccine 3 weeks after experimental infection with Mycobacterium bovis increased the inflammatory response, but not tuberculous pathology.
    Buddle BM; Shu D; Parlane NA; Subharat S; Heiser A; Hewinson RG; Vordermeier HM; Wedlock DN
    Tuberculosis (Edinb); 2016 Jul; 99():120-127. PubMed ID: 27450013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium bovis Δmce2 double deletion mutant protects cattle against challenge with virulent M. bovis.
    Blanco FC; Bianco MV; Garbaccio S; Meikle V; Gravisaco MJ; Montenegro V; Alfonseca E; Singh M; Barandiaran S; Canal A; Vagnoni L; Buddle BM; Bigi F; Cataldi A
    Tuberculosis (Edinb); 2013 May; 93(3):363-72. PubMed ID: 23518075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens.
    Buddle BM; Parlane NA; Keen DL; Aldwell FE; Pollock JM; Lightbody K; Andersen P
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):1-5. PubMed ID: 9874655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Cell Composition and Cytokine Expression Within Lymph Node Granulomas from BCG-Vaccinated and Non-vaccinated Cattle Experimentally Infected with Mycobacterium bovis.
    Salguero FJ; Gibson S; Garcia-Jimenez W; Gough J; Strickland TS; Vordermeier HM; Villarreal-Ramos B
    Transbound Emerg Dis; 2017 Dec; 64(6):1734-1749. PubMed ID: 27615603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disseminated BCG disease revealing a partial deficiency in receptor 1 interferon gamma].
    Antonietti J; Retornaz K; Bernasconi A; Laporte RJ; Minodier P; Bustamante JC; Dubus JC
    Arch Pediatr; 2015 Sep; 22(9):971-3. PubMed ID: 26251056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by
    Zatarain-Barrón ZL; Ramos-Espinosa O; Marquina-Castillo B; Barrios-Payán J; Cornejo-Granados F; Maya-Lucas O; López-Leal G; Molina-Romero C; Anthony RM; Ochoa-Leyva A; De La Rosa-Velázquez IA; Rebollar-Vega RG; Warren RM; Mata-Espinosa DA; Hernández-Pando R; van Soolingen D
    Front Immunol; 2020; 11():930. PubMed ID: 32508826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric detection of gamma interferon can effectively discriminate Mycobacterium bovis BCG-vaccinated cattle from M. bovis-infected cattle.
    Sopp P; Howard CJ; Hope JC
    Clin Vaccine Immunol; 2006 Dec; 13(12):1343-8. PubMed ID: 17005929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
    Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J
    Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vaccination of badgers (Meles meles) with BCG and protective immunity against endobronchial challenge with Mycobacterium bovis.
    Corner LA; Costello E; O'Meara D; Lesellier S; Aldwell FE; Singh M; Hewinson RG; Chambers MA; Gormley E
    Vaccine; 2010 Aug; 28(38):6265-72. PubMed ID: 20637774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle.
    Mustafa AS; Skeiky YA; Al-Attiyah R; Alderson MR; Hewinson RG; Vordermeier HM
    Infect Immun; 2006 Aug; 74(8):4566-72. PubMed ID: 16861643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis.
    De Lisle GW; Wilson T; Collins DM; Buddle BM
    Infect Immun; 1999 May; 67(5):2624-6. PubMed ID: 10225931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.